Pharmaceutical compounding (503B) is compounding pharmacies with outsourcing facilities that may manufacture large batches with or without prescriptions to be sold to healthcare facilities for office use only. 503B compounding pharmacies that provide patient-specific medications are held to higher regulatory standards. These facilities must comply with current good manufacturing practices (CGMP).
Community Discussions
Community Discussions
May 09, 2024
May 09, 2024
May 09, 2024
May 08, 2024
Data Integrity
GAMP
Information Systems
Pharma 4.0
May 08, 2024
May 06, 2024
May 05, 2024